Market Indexes
Table of Contents
Market Indexes
Stock market indexes represent a group of shares that have been selected based on certain criteria, such as trading volume, share size, etc. In the stock market, the sampling method is used to illustrate the direction of the market and movement through an index.
What are market indexes?
A stock market index is a statistical measure of the relative changes in the value of a portfolio of stocks. The Dow Jones Industrial Average (DJIA) and the Standard & Poor’s 500 Index (S&P 500) are the most commonly used stock market indices.
The DJIA is a price-weighted average of 30 blue-chip stocks widely considered a barometer of the overall US stock market. The S&P 500 is a market-cap-weighted index of 500 large-cap stocks widely considered representative of the US stock market.
Understanding market indexes
A stock market index keeps tabs on the performance and price changes of the stocks that make up the index. This indicates that the performance of the stocks that make up any stock market index is directly correlated with the index’s performance. In layman’s terms, the index generally increases if the prices of the stocks in it rises.
Equities with comparable market capitalisations, company sizes, or industry sectors are combined to create stock market indices. After that, the index is calculated using the chosen stocks. Nevertheless, the price of each stock will be unique, and the price point in one stock will differ from the price point in another. Therefore, it is impossible to calculate the index value by adding stock prices.
Types of market indexes
There are three main types of stock market indexes in the United States: the Dow Jones Industrial Average (DJIA), the Nasdaq Composite, and the S&P 500.
- Dow Jones Industrial Average (DJIA)
The DJIA is the oldest and most well-known index and consists of 30 large blue-chip stocks traded on the New York Stock Exchange (NYSE).
- Nasdaq composite
The Nasdaq Composite is a newer index that includes all stocks traded on the Nasdaq stock exchange, including both large and small companies.
- S&P 500
The S&P 500 is a broad-based index that includes 500 large-cap stocks traded on the NYSE and Nasdaq.
Advantages of market indexes
Stock market indexes are a useful tool for investors to track the stock market’s overall performance. By tracking the performance of a broad range of stocks, indexes can give investors a good indication of how the stock market is performing.
This can help make investment decisions, as it can indicate whether the stock market is bullish or bearish.
In addition to giving investors an overview of the market, indexes can also be used to measure the performance of specific market sectors. For example, the S&P 500 is divided into 11 different sectors including energy, materials, industrials, consumer discretionary, and healthcare. This can help identify which sectors are performing well and which are struggling.
Overall, stock market indexes are a useful tool for investors to track the stock market’s performance and make informed investment decisions.
Disadvantages of market indexes
While stock market indexes can provide a quick snapshot of how a particular market is performing, they also have some disadvantages. For example, because indexes are created using a weighted average of the stocks within the index, they may not accurately reflect the performance of any one particular stock. Additionally, because indexes only track a limited number of stocks, they may not provide a true representation of the entire market.
Frequently Asked Questions
A stock index list is a list of stocks grouped based on certain criteria. A panel of experts usually chooses the stocks in an index list designed to represent the stock market’s overall performance or a specific economic sector. Investors often use index lists to track the performance of the market or a specific sector.
A weighted index is a stock market index in which each component stock is assigned a weight, or a value, based on its market capitalization. The weight of a stock is determined by its market capitalization, which is the total value of all the outstanding shares of that stock. The weighting of the stocks in the index makes it a “weighted” index.
Investors use stock market indices for a variety of purposes, such as:
- To measure the performance of a particular stock market or market sector.
- To compare the relative performance of different stock markets or market sectors.
- To provide a benchmark for active portfolio managers.
- To help investors formulate investment strategies.
- To track the performance of exchange-traded funds and index mutual funds.
To read a stock market index, one must first understand its measures. A stock market index is a statistical average that measures the performance of a group of stocks. This can be done by taking the weighted average of the prices of the stocks in the group.
The index can be either a value or a growth index. A value index measures the stocks in the group based on their current prices. A growth index measures the stocks in the group based on their prices and dividend growth.
You must also know how the index is calculated. Once you understand what the index is measuring and how it is calculated, you can start interpreting it. The index can be used to measure the stock market’s overall performance. It can also be used to compare the performance of different groups of stocks. For example, you can compare the performance of large-cap stocks to small-cap stocks.
Understanding what the stock market index measures is the first step to reading it. Once you understand what it measures, you can interpret it and use it to make decisions about investing in the stock market.
A stock index, sometimes known as a stock market index, is an indicator used in finance to evaluate a stock market or a segment of a stock market and assist investors in comparing current stock prices to historical prices to determine market performance.
Equities from comparable companies or those that meet a predefined set of criteria are chosen to create a stock market index. These securities are already traded and listed on the exchange. Market capitalization, industry, and other factors may all be used to create share market indices.
Related Terms
- Cost of Equity
- Capital Adequacy Ratio (CAR)
- Interest Coverage Ratio
- Industry Groups
- Income Statement
- Historical Volatility (HV)
- Embedded Options
- Dynamic Asset Allocation
- Depositary Receipts
- Deferment Payment Option
- Debt-to-Equity Ratio
- Financial Futures
- Contingent Capital
- Conduit Issuers
- Calendar Spread
- Cost of Equity
- Capital Adequacy Ratio (CAR)
- Interest Coverage Ratio
- Industry Groups
- Income Statement
- Historical Volatility (HV)
- Embedded Options
- Dynamic Asset Allocation
- Depositary Receipts
- Deferment Payment Option
- Debt-to-Equity Ratio
- Financial Futures
- Contingent Capital
- Conduit Issuers
- Calendar Spread
- Devaluation
- Grading Certificates
- Distributable Net Income
- Cover Order
- Tracking Index
- Auction Rate Securities
- Arbitrage-Free Pricing
- Net Profits Interest
- Borrowing Limit
- Algorithmic Trading
- Corporate Action
- Spillover Effect
- Economic Forecasting
- Treynor Ratio
- Hammer Candlestick
- DuPont Analysis
- Net Profit Margin
- Law of One Price
- Annual Value
- Rollover option
- Financial Analysis
- Currency Hedging
- Lump sum payment
- Annual Percentage Yield (APY)
- Excess Equity
- Fiduciary Duty
- Bought-deal underwriting
- Anonymous Trading
- Fair Market Value
- Fixed Income Securities
- Redemption fee
- Acid Test Ratio
- Bid Ask price
- Finance Charge
- Futures
- Basis grades
- Short Covering
- Visible Supply
- Transferable notice
- Intangibles expenses
- Strong order book
- Fiat money
- Trailing Stops
- Exchange Control
- Relevant Cost
- Dow Theory
- Hyperdeflation
- Hope Credit
- Futures contracts
- Human capital
- Subrogation
- Qualifying Annuity
- Strategic Alliance
- Probate Court
- Procurement
- Holding company
- Harmonic mean
- Income protection insurance
- Recession
- Savings Ratios
- Pump and dump
- Total Debt Servicing Ratio
- Debt to Asset Ratio
- Liquid Assets to Net Worth Ratio
- Liquidity Ratio
- Personal financial ratios
- Payroll deduction plan
- Operating expenses
- Demand elasticity
- Deferred compensation
- Conflict theory
- Acid-test ratio
- Withholding Tax
- Benchmark index
- Double Taxation Relief
- Debtor Risk
- Securitization
- Yield on Distribution
- Currency Swap
- Overcollateralization
- Efficient Frontier
- Listing Rules
- Green Shoe Options
- Accrued Interest
- Market Order
- Accrued Expenses
- Target Leverage Ratio
- Acceptance Credit
- Balloon Interest
- Abridged Prospectus
- Data Tagging
- Perpetuity
- Optimal portfolio
- Hybrid annuity
- Investor fallout
- Intermediated market
- Information-less trades
- Back Months
- Adjusted Futures Price
- Expected maturity date
- Excess spread
- Quantitative tightening
- Accreted Value
- Equity Clawback
- Soft Dollar Broker
- Stagnation
- Replenishment
- Decoupling
- Holding period
- Regression analysis
- Wealth manager
- Financial plan
- Adequacy of coverage
- Actual market
- Credit risk
- Insurance
- Financial independence
- Annual report
- Financial management
- Ageing schedule
- Global indices
- Folio number
- Accrual basis
- Liquidity risk
- Quick Ratio
- Unearned Income
- Sustainability
- Value at Risk
- Vertical Financial Analysis
- Residual maturity
- Operating Margin
- Trust deed
- Profit and Loss Statement
- Junior Market
- Affinity fraud
- Base currency
- Working capital
- Individual Savings Account
- Redemption yield
- Net profit margin
- Fringe benefits
- Fiscal policy
- Escrow
- Externality
- Multi-level marketing
- Joint tenancy
- Liquidity coverage ratio
- Hurdle rate
- Kiddie tax
- Giffen Goods
- Keynesian economics
- EBITA
- Risk Tolerance
- Disbursement
- Bayes’ Theorem
- Amalgamation
- Adverse selection
- Contribution Margin
- Accounting Equation
- Value chain
- Gross Income
- Net present value
- Liability
- Leverage ratio
- Inventory turnover
- Gross margin
- Collateral
- Being Bearish
- Being Bullish
- Commodity
- Exchange rate
- Basis point
- Inception date
- Riskometer
- Trigger Option
- Zeta model
- Racketeering
- Short Selling
- Quartile rank
- Defeasance
- Cut-off-time
- Business-to-Consumer
- Bankruptcy
- Acquisition
- Turnover Ratio
- Indexation
- Fiduciary responsibility
- Benchmark
- Pegging
- Illiquidity
- Backwardation
- Backup Withholding
- Buyout
- Beneficial owner
- Contingent deferred sales charge
- Exchange privilege
- Asset allocation
- Maturity distribution
- Letter of Intent
- Emerging Markets
- Consensus Estimate
- Cash Settlement
- Cash Flow
- Capital Lease Obligations
- Book-to-Bill-Ratio
- Capital Gains or Losses
- Balance Sheet
- Capital Lease
Most Popular Terms
Other Terms
- Bond Convexity
- Compound Yield
- Brokerage Account
- Discretionary Accounts
- Industry Groups
- Growth Rate
- Green Bond Principles
- Gamma Scalping
- Funding Ratio
- Free-Float Methodology
- Foreign Direct Investment (FDI)
- Floating Dividend Rate
- Flight to Quality
- Real Return
- Protective Put
- Perpetual Bond
- Option Adjusted Spread (OAS)
- Non-Diversifiable Risk
- Merger Arbitrage
- Liability-Driven Investment (LDI)
- Income Bonds
- Guaranteed Investment Contract (GIC)
- Flash Crash
- Equity Carve-Outs
- Cost Basis
- Deferred Annuity
- Cash-on-Cash Return
- Earning Surprise
- Bubble
- Beta Risk
- Bear Spread
- Asset Play
- Accrued Market Discount
- Ladder Strategy
- Junk Status
- Intrinsic Value of Stock
- Interest-Only Bonds (IO)
- Inflation Hedge
- Incremental Yield
- Industrial Bonds
- Holding Period Return
- Hedge Effectiveness
- Flat Yield Curve
- Fallen Angel
- Exotic Options
- Execution Risk
- Exchange-Traded Notes
- Event-Driven Strategy
- Eurodollar Bonds
- Enhanced Index Fund
Know More about
Tools/Educational Resources
Markets Offered by POEMS
Read the Latest Market Journal
Investing in the AI Revolution: A Guide to Semiconductor & Ecosystem ETFs
The rapid surge in artificial intelligence (AI), generative models, cloud computing, and autonomous systems has propelled semiconductors from a niche cyclical sector into the primary engine of the global technology megatrend. From graphic processing units (GPUs) and high-bandwidth memory (HBM) to advanced lithography equipment, chipmakers form the foundational hardware layer of modern innovation. For investors seeking to capture this structural growth wave without taking on single-stock concentration risk, Semiconductor ETFs (Exchange-Traded Funds) offer an efficient, liquid gateway. Source: Generative Value, 2024 1. Why Invest in Semiconductor & Ecosystem ETFs? The AI & Compute Supercycle Semiconductors are no longer tied solely to consumer electronics replacement cycles. The commercialisation of AI and high-performance computing (HPC) has initiated a multi-year capex expansion cycle among hyper-scalers and sovereign tech initiatives. S&P Global and market research benchmarks project global semiconductor industry revenues to surpass $1.5 Trillion annually by 2030, driven predominantly by AI accelerators, automotive electrification, and edge computing (Reuters, 2026). Full Ecosystem Coverage Beyond Single Giants While mega-cap chip designers frequently dominate headlines, a semiconductor ETF provides diversified exposure across the entire value chain helping capture growth opportunities across the industry's interconnected ecosystem: Fabless Chip Designers:Companies focused purely on chip architecture and software (e.g., Nvidia, AMD, Qualcomm). Pure-Play Foundries: Specialised manufacturers producing physical silicon wafers (e.g., TSMC, SMIC). Semiconductor Equipment Manufacturers: Suppliers of critical photolithography and fabrication machinery (e.g., ASML, Applied Materials, Lam Research). Outsourced Semiconductor Assembly & Test (OSAT): Advanced packaging and testing specialists critical for multi-die chip architectures. 2. Global Semiconductor ETF Landscape: US, Hong Kong & Singapore Investors can access semiconductor exposure across different listing venues depending on their geographic preference, currency choice, and structural tilt (e.g., mega-cap concentration vs. equal-weighted mid-caps). Overview of ETF Options Ticker / Exchange Name Primary Strategy / Focus Market Cap & Exposure Type Expense Ratio SMH (US) VanEck Semiconductor ETF Global Chip Leaders (US-Listed) Mega-Cap / Highly Concentrated (Top holdings 10–25%+)25-26 Companies 0.35% SOXX (US) iShares Semiconductor ETF Market-Cap Benchmark (30 Stocks) Broad Large-Cap Focus with Capped Single-Stock Weights30 Primary Companies total 34-35 holdings 0.35% SOXQ (US) Invesco PHLX Semiconductor ETF Low-Cost Benchmark (PHLX Index) Broad Large-Cap Core Exposure30-33 holdings 0.19% XSD (US) SPDR S&P Semiconductor ETF Equal-Weighted Index High Mid/Small-Cap Tilt; Reduced Single-Stock Risk46 component stocks 0.35% PSI (US) Invesco Dynamic Semiconductors ETF Factor-Based (Quant/Smart Beta) Dynamic Tilt toward Growth, Momentum & Value30-33 holdings 0.56% 3119 (HKEX) Global X Asia Semiconductor ETF Pan-Asia Chip Ecosystem Regional Focus (Taiwan, South Korea, Japan, China)40-41 holdings 0.68% 3191 (HKEX) Global X China Semiconductor ETF Domestic China Supply Chain China Onshore/Offshore Pure-Play Champions20-30 holdings 0.68% HST / HSS (SGX) Lion-OCBC Sec Hang Seng TECH ETF Broad Tech & Hardware (Hang Seng TECH) Tech Ecosystem (Includes Foundry & Tech Giants)30 holdings 0.56% a. Mega-Cap & Pure-Play Dominance (US Listed) Funds like the VanEck Semiconductor ETF (SMH) adopt a market-cap weighting scheme that allows top-tier market winners (e.g., Nvidia, TSMC) to occupy substantial percentages of the portfolio. This makes SMH ideal for investors who want aggressive exposure to frontline AI category leaders. b. Broad Market-Cap Benchmarks (US Listed) The iShares Semiconductor ETF (SOXX) and the low-cost Invesco PHLX Semiconductor ETF (SOXQ) provide structured, broad-based exposure to large, established chip manufacturers. By enforcing single-stock weighting caps (typically 8% to 12% per name), these ETFs mitigate extreme single-company downside. c. Mid-Cap, Small-Cap & Factor-Based Strategies (US Listed) Equal-Weighting (XSD): The SPDR S&P Semiconductor ETF (XSD) assigns equal weight to every constituent index member. This strategy reduces reliance on mega-cap valuations while boosting exposure to high-growth mid-cap and small-cap chip designers. Smart Beta / Factor Selection (PSI): The Invesco Dynamic Semiconductors ETF (PSI) evaluates holdings using quantitative metrics such as price momentum, earnings quality, and fundamental value. d. Asian & Regional Supply Chain Coverage (HKEX & SGX Listed) The Global X Asia Semiconductor ETF (3119.HK) focuses on Pan-Asian Manufacturing Hubs and tracks Asia-Pacific leaders across Taiwan, South Korea, and Japan. The ETF also provides targeted exposure to advanced foundry capacity and memory (HBM/DRAM) producers. The Global X China Semiconductor ETF (3191.HK) targets the China Localised Ecosystem with an emphasis on domestic Chinese semiconductor firms that accelerates localisation efforts in fabrication and equipment. The Lion-OCBC Securities Hang Seng TECH ETF (HST.SI / HSS.SI), listed on the SGX, in both SGD and USD counters, gives local investors easy, direct access to Asian tech giants and key regional foundries (such as SMIC) within a unified multi-currency instrument. 3. Key Risks in Semiconductor Investing While structural tailwinds remain compelling, semiconductor investments exhibit elevated volatility: Cyclical Demand Signals: Despite long-term AI growth, chipmaker revenues remain subject to short-term inventory corrections, demand swings in consumer hardware, and variable enterprise IT spending. Geopolitical & Supply Chain Bottlenecks: Advanced semiconductor manufacturing is geographically concentrated in East Asia. Trade restrictions, export controls on advanced lithography machinery, and national security policies can trigger rapid repricing. High Valuation Multiples: Fast-growing semiconductor design names frequently trade at elevated price-to-earnings (P/E) ratios, making them vulnerable to sharp drawdowns during interest rate spikes or temporary earnings misses. 4. Investor Checklist: Evaluating a Semiconductor ETF Before allocating capital, evaluate the following variables on the fund’s factsheet: Top Holdings Concentration: Determine if the fund is top-heavy (e.g., top 3 holdings exceeding 30–40% of total assets) or evenly distributed. Segment Allocation (Fabless vs. Foundry vs. Equipment): Check whether the fund favours chip designers (higher margins, asset-light) or equipment and foundry operators (capital intensive, structural moats). Index Weighting Rules: Confirm whether the benchmark uses pure market-cap weighting, capped market-cap weighting, or equal weighting. Expense Ratio & Trading Spread: Compare total holding costs (expense ratios range from ~0.19% to 0.68%) and check average daily trading volumes to ensure minimal bid-ask slippage. 5. Strategic Implementation for Investors Core-Satellite Portfolio Structure A practical approach to capturing the technology megatrend involves pairing a broad global equity allocation with a specialised semiconductor satellite (a satellite position is a smaller, targeted investment holding (usually 10% to 30% of a portfolio) : Core Position (70–90%): Broad global or developed market index fund (e.g., S&P 500 or MSCI World). Satellite Position (10–30%): A semiconductor ETF (SMH for mega-cap growth, XSD for mid-cap tilt, or 3119.HK / HST.SI for regional Asian diversification). Exchange Selection & Multi-Currency Flexibility Asian and Singapore-based investors can choose listing venues to optimise execution and convenience: US-Listed ETFs (SMH, SOXX, XSD): Offer the highest trading volume and lowest expense ratios, traded in USD during US market hours. HKEX/SGX-Listed ETFs (3191.HK, HST.SI): Allow trading during Asian market hours without the need for foreign exchange conversions when using local SGD or HKD counters. In Summary The semiconductor sector remains a key enabler of long-term technology trends, from artificial intelligence and cloud computing to automotive innovation and advanced manufacturing. This article has highlighted a range of semiconductor ETFs that investors may consider, each offering different levels of diversification, geographic exposure, concentration risk, liquidity, trading venues, and cost structures. When evaluating whether an ETF deserves a place in your portfolio, consider factors such as its investment objective, underlying holdings, geographic and sector exposure, expense ratio, trading liquidity, costs structure, and how well it aligns with your investment goals and risk tolerance. Investors should also assess whether the ETF provides broad industry exposure or a more concentrated bet on specific semiconductor companies or themes. References 1. https://www.reuters.com/world/asia-pacific/tsmc-says-global-chip-market-hit-15-trillion-by-2030-ai-drives-growth-2026-05-14/ 2. https://www.generativevalue.com/p/a-primer-on-semiconductor-capital DisclaimerDisclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.
Ever Glory United Holdings Ltd – Order Book Surges Past S$1bn
Brief Overview Ever Glory United Holdings delivered strong 1H26 results, with revenue and adjusted profit after tax and minority interest (PATMI) exceeding expectations at 84% and 94% of full-year forecasts respectively. The company's order book surged 220% year-on-year to more than S$1bn following the securing of over S$400mn in new contracts during 2026. Phillip Securities Research maintains a BUY recommendation with a raised target price of S$1.20. Investment Positives The primary driver of Ever Glory's growth has been the consolidation of Guthrie's results following the acquisition. The company's adjusted PATMI accelerated 208% year-on-year to S$14.1mn in 1H26, compared to 98% growth in 2H25. This growth was driven by the consolidation and recognition of Guthrie's mechanical and electrical (M&E) works, particularly progress on combined M&E projects including maintenance of street lighting and bus depot facility upgrades. The company's order book represents a significant positive, having surged more than 220% year-on-year to exceed S$1bn. Ever Glory secured more than S$400mn in new contracts during 2026, including S$168mn combined value for an offshore defence infrastructure project and M&E contracts in commercial mixed developments. This substantial order book is expected to support growth through 2029. The company has also strengthened its financial position, with net debt reducing by 86% year-on-year to S$716,000, supported by a S$19mn year-on-year increase in operating cash flow. This improved balance sheet has enabled Ever Glory to recommend interim dividends of 0.75 cents per share, representing a 29% payout ratio, compared to no interim dividend in 1H25. Investment Negatives The report does not explicitly outline specific investment negatives or risks facing Ever Glory United Holdings. Outlook Ever Glory appears well-positioned for continued growth, with management believing the company can secure additional high-value M&E contracts. Potential future awards include Integrated General Hospital projects worth more than S$200mn per M&E project, Changi T5 buildings and runway lighting worth S$1bn or more for M&E work, and LTA MRT tunnel lighting projects. Recommendation & Target Price Phillip Securities Research maintains a BUY recommendation on Ever Glory United Holdings with a raised target price of S$1.20, increased from the previous target of S$1.05. The analysts raised FY26 revenue and PATMI forecasts by 57% and 62% respectively due to the consolidation of Guthrie's results. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst. Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.
Singapore REITs Monthly – Strong DPU Growth in 1H26
Brief Overview The Singapore REITs sector delivered a solid performance in July with the S-REITs Index gaining 3%, building on June's 0.4% increase. Results for 1H26 showed impressive strength, with S-REITs under coverage achieving approximately 6% average distribution per unit (DPU) growth year-on-year, excluding Prime US REIT's exceptional 316% growth. Phillip Securities Research maintains an overweight stance on the sector whilst remaining selective given uncertain interest rate conditions. Investment Positives The 1H26 results demonstrate the sector's underlying resilience, with DPU growth driven by three key factors. Financing costs declined by approximately 20 basis points year-on-year on average, providing material support to distributions. Operating performance remained resilient, supported by higher rents across portfolios. Additionally, completed asset enhancement initiatives (AEIs) and accretive acquisitions contributed meaningfully to growth. Individual REIT performance highlights the sector's momentum, with Suntec REIT and OUE REIT recording particularly strong DPU growth of 24.8% and 28.6% respectively, driven by lower financing costs and resilient performance across their Singapore assets. The 3-month SORA has stabilised at around 1.15%, remaining approximately 70 basis points lower year-on-year, continuing to benefit S-REITs with SGD-denominated loans through reduced borrowing costs. Transaction activity remains robust, with over S$8 billion of acquisitions and more than S$5 billion of divestments year-to-date, including significant deals such as CICT's S$3.9 billion acquisition of Paragon Mall. The retail sub-sector shows particularly strong fundamentals, with 1H26 performance characterised by near-full occupancy and rental reversions ranging from mid-single digits to low teens. This performance is underpinned by 17% growth in tenant sales, steady footfall, and limited new supply. The supply outlook remains favourable, with forecast average annual gross new supply of approximately 0.5 million square feet from 2026 to 2029, below historical averages. Investment Negatives Despite the positive momentum, analysts highlight concerns about interest rate volatility given the uncertain outlook. The macroeconomic backdrop remains volatile amid the possibility of a Federal Reserve rate hike, which could impact transaction momentum and financing costs. Outlook Analysts expect the positive momentum to continue into 2H26, forecasting approximately 4% average DPU growth for covered S-REITs, supported by organic rental growth, accretive acquisitions, and lower financing costs. Transaction activity is expected to continue but at a slower pace given macroeconomic uncertainties. For retail S-REITs specifically, FY26e rental reversions are expected to remain in the mid-to-high-single-digit range. Recommendation & Target Price Phillip Securities Research maintains an overweight recommendation on Singapore REITs, favouring those with robust balance sheets, defensive earnings profiles and high proportions of fixed-rate debt. The firm's top picks are Stoneweg Europe Stapled Trust (BUY, target price €1.89), Elite UK REIT (BUY, target price £0.41), and United Hampshire US REIT (BUY, target price US$0.69). Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst. Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.
17LIVE Group Limited – Coverage Ceasing as Company Pursues Diversification Strategy
Brief Overview Phillip Securities Research has announced it will cease coverage of 17LIVE Group Limited following its latest results review. The company reported a 19.4% year-on-year revenue decline to US$65.4 million in 1H26, driven by falling active users and flat average revenue per user growth. Despite revenue challenges, the net loss narrowed significantly from US$4.6 million to US$1.6 million, supported by cost-optimisation efforts. The company is pursuing diversification through live commerce and AI-driven content production. Investment Positives The analyst highlights several encouraging developments for 17LIVE's operational efficiency and strategic direction. Cost-optimisation efforts have proven effective, with the company successfully narrowing its net loss by approximately 65% year-on-year from US$4.6 million in 1H25 to US$1.6 million in 1H26. This demonstrates management's ability to control expenses during a challenging period. The company's diversification strategy presents potential new revenue streams beyond its traditional livestreaming business. 17LIVE plans to expand into live commerce, which could provide additional monetisation opportunities. The company is also venturing into short-drama and AI-driven drama production, specifically targeting the Japanese market through revenue-sharing partnerships with short-drama platforms. Technology enhancements to the core business show promise for future growth. The company plans to launch AI Co-Host functionality and expand its 17Animaker tool more broadly. These innovations are designed to enhance streamer productivity and improve user engagement, potentially addressing some of the user retention challenges. Investment Negatives The core business metrics present significant concerns. Revenue declined substantially by 19.4% year-on-year to US$65.4 million in 1H26, indicating weakening demand for the company's services. This decline was driven by two critical factors: a reduction in active users and flat average revenue per user growth, suggesting both user acquisition and monetisation challenges. Profitability remains elusive despite cost-cutting measures. The company continued to be loss-making during 1H26, with earnings falling below analyst expectations compared to the FY26 forecast of US$3.8 million in profit after tax and minority interests. Outlook 17LIVE's 1H26 revenue represented 45% of the full-year FY26 forecast, indicating the company needs significant improvement in the second half to meet projections. The success of diversification initiatives, particularly in live commerce and Japanese short-drama partnerships, will be crucial for future performance. Recommendation & Target Price Following this report, Phillip Securities Research will cease coverage of 17LIVE due to the reallocation of coverage resources. No specific recommendation or target price was provided in this final coverage report. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst. Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.
BRC Asia Ltd – PATMI accelerates, balance sheet strengthens
Brief Overview BRC Asia provided a 3Q26 update with limited financials, showing results within expectations. The company delivered 9M26 revenue and PATMI at 70% and 72% of full-year forecasts respectively. Notable developments included PATMI acceleration of 25% year-on-year to S$27.3 million, whilst revenue growth decelerated to 4.8% due to Changi T5 project timing issues. The company maintains a strong net cash position of S$60.4 million. Investment Positives BRC Asia demonstrated strong operational performance through accelerated PATMI growth of 25% year-on-year to S$27.3 million in 3Q26. This growth was driven by elevated steel rebar volumes delivered, which created operating leverage benefits. The company delivered an estimated 600,000 tons of steel rebar in 3Q26, representing a substantial 45% increase compared to the average of approximately 420,000 tons delivered quarterly over the past seven years. Profitability improvements were further supported by lower provisions for onerous contracts, contributing to gross margin expansion of 40 basis points year-on-year to 11.4%. This demonstrates the company's ability to improve operational efficiency whilst managing project risks. The balance sheet position has strengthened considerably. BRC Asia maintained its strong net cash position of S$60.4 million, improving from S$52 million in 1H26. This was supported by a significant rebound in 3Q26 operating cash flow to S$33 million, compared to negative S$8.5 million in 3Q25. This robust financial position enables the group to maintain its dividend payout ratio at 58% in FY26e, providing an attractive yield of approximately 5.5%. Investment Negatives Revenue growth momentum has decelerated significantly. 3Q26 revenue growth slowed to 4.8% year-on-year, marking the smallest growth rate since 2Q25. This deceleration was primarily attributed to reduced rebar volume growth, which dropped to approximately 3.5% year-on-year in 3Q26, compared to an estimated 46% in 2Q26. The slowdown resulted from a reorganisation of Changi T5 works, which affected project timing and delivery schedules. However, the analyst expects rebar volume delivery to strengthen in 4Q26e and into 1H27e as project offtake continues. Outlook The analyst believes BRC Asia's strong balance sheet provides sufficient headroom to maintain dividend distributions whilst supporting future growth. The temporary impact from Changi T5 project reorganisation is expected to resolve, with volume delivery anticipated to strengthen in upcoming quarters. Recommendation & Target Price Phillip Securities Research maintains a BUY recommendation with an unchanged DCF-derived target price of S$5.30. The analyst lowered FY26e revenue and PATMI forecasts by 5% and 3% respectively due to slight delays in the Changi T5 project. The WACC was reduced to 10.3% from 10.5% due to BRC Asia's stronger net cash position. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst. Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.
ComfortDelGro Faces Persistent Taxi Headwinds Despite UK Bus Contract Improvements
Brief Overview ComfortDelGro Corp Ltd delivered underwhelming first-half results, with 1H26 revenue and PATMI reaching only 46% and 44% of full-year expectations respectively. The company's taxi operations remain severely challenged across multiple markets, whilst the UK bus business provided some relief through contract repricing. Management maintained the interim dividend at 3.91 cents despite the earnings decline. Investment Positives The primary bright spot remains ComfortDelGro's London bus operations, specifically through Metroline. The recontracting of Metroline London contracts to higher margins has successfully driven UK earnings growth, with public transport earnings advancing 11% higher in 1H26. Approximately 70% of the repricing process has been completed, indicating further potential benefits ahead. This strategic repricing demonstrates management's ability to negotiate improved terms in at least one segment of their diversified transport portfolio. Investment Negatives Taxi operations represent the company's most significant challenge, with earnings plummeting 46% year-on-year to S$36.6 million in 1H26. The weakness spans multiple geographic markets, creating a broad-based deterioration in this core segment. In Singapore, the taxi fleet continues shrinking, whilst Australia faces soft consumer demand pressures. The UK taxi operations encountered specific disruption through the A2B premium taxi service, where a major Middle Eastern airline customer cancelled flights or operated with reduced capacity due to Middle East conflict impacts. The company's substantial acquisition strategy has failed to deliver expected results, with approximately S$850 million worth of acquisitions not producing the anticipated earnings turnaround. Operating conditions have worsened across Australia and the UK markets, suggesting systemic rather than isolated challenges. Outlook The analyst expects taxi segment weakness to persist into the second half of 2H26, indicating no near-term recovery prospects. The structural headwinds affecting taxi operations are described as both worsening and spreading across markets, suggesting deeper industry-wide challenges rather than company-specific issues. Recommendation & Target Price Phillip Securities Research maintains a NEUTRAL recommendation on ComfortDelGro Corp Ltd. The target price has been reduced to S$1.21 from the previous S$1.35, reflecting deteriorating prospects. The firm has lowered FY26 earnings estimates by 7% to S$177 million. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst. Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.
Hyphens Pharma International Maintains Growth Trajectory Despite Near-Term Headwinds
Brief Overview Hyphens Pharma International reported 1H26 results that met expectations, with revenue and adjusted profit after tax and minority interests (adj.PATMI) reaching 48% and 42% of full-year forecasts respectively. Revenue remained largely flat at S$89.1mn, whilst adj.PATMI declined 11% year-on-year due to increased distribution costs. The company is strategically building its product portfolio breadth and scale, though this requires higher upfront investments across multiple areas. Investment Positives The standout positive development was the achievement of record gross margins. Gross profit margin improved by 2.8 percentage points to reach a record 42.3%, driving gross profit up 6.6% to S$37.6mn. This margin expansion was supported by the company's strategic focus on higher-margin products, with prescription drugs under speciality pharma representing the highest-margin segment. The margin improvement also reflects the discontinuation of lower-margin products such as Physiolac, demonstrating management's commitment to portfolio optimisation. Key growth products driving the business forward include Cerapro MED for atopic dermatitis, Winlevi for anti-acne treatment, Ceradan for skin repair, and D-Cure vitamin D supplement. From a balance sheet perspective, Hyphens maintains a strong financial position with net cash of S$23mn, providing flexibility for continued investment and growth initiatives. Investment Negatives The primary headwind facing the company is rising operating expenses, which climbed 8% to S$30mn, representing an increase of S$2.2mn. This increase effectively offset the S$2.3mn gain in gross profit, highlighting the pressure on operating margins. The expense increases were driven by additional investments in marketing, which rose by S$1.1mn, and staff costs, which increased by S$1mn. These higher advertising and employee expenses pulled down operating profit despite the improved gross margins. Outlook Hyphens is positioned for stronger second-half earnings, with the company continuing to build the breadth and scale of its product offerings. The strategic investments in employee, marketing and research costs are expected to support longer-term growth prospects. Recommendation & Target Price Phillip Securities Research maintains a BUY recommendation on Hyphens Pharma International with a raised target price of S$0.46, up from the previous target after lowering DCF risk assumptions. The stock trades at an attractive valuation of 9x price-to-earnings ratio. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst. Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.
SATS Ltd Shows Strong Cargo and Food Performance Despite SoAJV Challenges
Brief Overview SATS Ltd reported strong first-quarter results with revenue and PATMI rising 11.3% and 5.9% year-on-year to S$1,676.3 million and S$75.1 million respectively, representing 28% and 25% of full-year forecasts. Cargo volumes increased 8.6% year-on-year driven by Americas demand, whilst food solutions revenue grew 5.4% supported by non-aviation expansion. Food solutions margins improved significantly by 1.6 percentage points to 14.1% despite inflationary pressures. Investment Positives The analyst highlights strong operational performance across key business segments. Cargo volumes demonstrated robust growth of 8.6% year-on-year to 2,585.1 thousand tonnes, with particularly strong performance in the Americas region showing 9.5% year-on-year growth. This expansion was underpinned by high-value, time-sensitive freight including servers, data storage units and memory chips used for AI data centre build-out. Food solutions emerged as another strong performer with revenue rising 5.4% year-on-year to S$346 million. Non-aviation food revenue showed impressive 16% year-on-year growth, supported by customer expansion in China, including Starbucks. The higher non-aviation food volumes drove greater utilisation of SATS' central kitchen and food factories, which have largely fixed costs, creating operating leverage and lowering unit costs. Additionally, ongoing repricing negotiations and a rerouting-driven benefit in the long-haul meal mix supported performance. Investment Negatives The report indicates challenges from margin compression due to elevated M&A transaction costs and SOAJV weakness stemming from low-cost carrier exposure, which resulted in an 18.8% decline in operating profit for that segment. Outlook The analyst expects normalisation in the coming quarters as margin compression from elevated M&A transaction costs and SOAJV weakness from low-cost carrier exposure should improve. Stronger food segment volumes are anticipated from effective utilisation of new facilities, with forecasts increased for FY28e and FY29e PATMI by 1% and 5% respectively. Recommendation & Target Price Phillip Securities Research maintains a BUY rating and has raised the DCF target price to S$5.01 from the previous S$4.52. SATS currently trades at 20.2x FY27e P/E. Frequently Asked Questions [market_journal_faq] This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst. Disclaimer These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries. Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned. This advertisement has not been reviewed by the Monetary Authority of Singapore.
